surpass 2 tirzepatide Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m surpass-2 tirzepatide vs semaglutide weight

Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype

Redox Biol 37:101715 Zhang J, Wang H, Yan X, Zhang L (2005) Comparison of short-term toxicity between Nano-Se and selenite in mice

Get medical help right away if you have: A rash over your whole body Shortness of breath Swelling of your face, tongue, or throat Extreme drowsiness, dizziness, or confusion Trouble breathing Fast heartbeat Sweating Toujeo may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching

On the contrast, carnitine supplementation (200 mg/kg/day) for 28 successive days showed non-significant changes

You see in Canada tirzepatide is formally approved for use in type 2 diabetes, however physicians regularly prescribe it off label (meaning for a condition it is not yet formally indicated by regulators) for use with obesity while we wait for Health Canada approval (the FDA approved it for obesity on November 8th, 2023, while the EUs European Commission approved it for obesity on April 24th, 2024)